DOCN (NYSE) insider sale reported — 20,000 shares for $1.11M disclosed
Rhea-AI Filing Summary
DOCN: A Form 144 notice lists proposed sales and recent dispositions by an insider or affiliate. The filing shows 25,000 shares and associated figures, records 20,000 shares sold on 03/03/2026 for $1,108,000.00, and details securities acquired via an ESPP (714 shares) and restricted stock vesting (24,286 shares).
Positive
- None.
Negative
- None.
Insights
Form 144 lists proposed sales and recent insider sales with issuer-reported basis.
The filing records a proposed/recorded sale quantity of 25,000 shares and a reported sale of 20,000 shares on 03/03/2026 for $1,108,000.00. It also itemizes recent issuances: 714 ESPP shares and 24,286 restricted shares vested.
Compliance hinges on timing and Rule 144 conditions; subsequent Form 4 or broker reports may show execution details. Future filings will clarify whether the remaining listed shares were sold and confirm proceeding amounts.
The disclosures are routine insider sale notices and compensation-related issuances.
The record separates compensation-originated shares (ESPP and vesting) from the transaction reported as sold. The entry for Fidelity Brokerage Services LLC with 25,000 suggests a broker/placement reporting line tied to the notice.
These items are administrative disclosures; investors usually treat them as routine unless followed by larger, unexpected disposals in subsequent filings.